Zodiac Partners II, LLC Launches a $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash

Stock Information for Arch Therapeutics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Arch Therapeutics Inc

Destination XL Group, Inc. Recommends DXL Shareholders Reject Zodiac Partners II's Tender Offer And NOT Tender Their Shares
Destination XL Group, Inc. to Review Unsolicited Tender Offer From Zodiac Partners II
Destination XL Group, Inc. to Announce First Quarter 2026 Financial Results on Thursday, May 28, 2026
Destination XL Group, Inc. Reports Fiscal 2025 Fourth Quarter and Full-Year Financial Results
Destination XL Group, Inc. to Announce Fourth Quarter and Fiscal 2025 Financial Results on March 19, 2026
Halper Sadeh LLC Encourages DHIL, UDMY, DXLG Shareholders to Contact the Firm to Discuss Their Rights
Destination XL Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Destination XL Group, Inc. - DXLG
Destination XL Group, Inc. Reports Holiday Sales Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.